Typicality: | 0.454 |
Saliency: | 0.380 |
to the research community | 9 | transitive-object |
to women | 4 | transitive-object |
always | 2 | degree |
trial → be → beneficial | 17 |
trial → have → benefit | 6 |
trial → have → the benefit | 5 |
trial → be → benefit | 4 |
negative | neutral | positive |
0.081 | 0.361 | 0.559 |
Raw frequency | 32 |
Normalized frequency | 0.380 |
Modifier score | 0.900 |
Perplexity | 237.257 |